All orders submitted through the Detect Hereditary Pancreatic Program will include analyses of both of the following panels (results will be delivered separately in two different reports):
Results of the Invitae BRCA1 and BRCA2 STAT Panel will be reported 5-12 days from sample accessioning. Accelerated turnaround time may be necessary because physicians and patients often want to make surgical and management decisions as quickly as possible.
The Invitae Multi-Cancer Panel is a comprehensive cancer panel that tests genes associated with hereditary cancer syndromes, including known pancreatic cancer genes. Results of the Invitae Multi-Cancer Panel will be reported separately within 21 days of delivery of the Invitae BRCA1 and BRCA2 STAT Panel report.
Clinicians can place an order by following the steps below (please note that the Detect Hereditary Pancreatic Cancer program only accepts paper orders).
To receive results:
If you're a patient and believe you are eligible for this sponsored testing program, you have options:
Contact Genome Medical
(available in US only)
Schedule a genetic counseling session, by phone or video, with an expert who can review your testing options and place the order. There is a cost associated with the Genome Medical services, which may be covered under your health benefits.
Discuss the program with your doctor
If you already have a healthcare provider who can place this order, you can download this flyer to take to your own provider.
Find a local genetics provider
Search our genetics providers network to find a provider in your area. Please sign in, or create an account, to connect with our network of professionals. There may be a cost associated with the provider’s services.
Individuals tested through the Detect Hereditary Pancreatic Cancer program will be eligible for no-charge, post-test genetic counseling to help them understand their test results. Invitae's genetic counseling services include:
Commitment to quality:
Invitae’s >1000 patient peer-reviewed study, published in the Journal Molecular Diagnostics, the official journal of the Association for Molecular Pathology, shows equivalence to established standards.
Sample options: blood and saliva kits provided free of charge.
Strong team: Invitae has more than 300 experts in genetics, bioinformatics, engineering, technology, and commercial development.
Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene tests today.
While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US and Canada only. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use, or support any other products or services from Invitae or from third parties or commercial organizations.